Triojection® has received Breakthrough Device Designation from the FDA.
Our pivotal “RELIEF” Trial has received FDA IDE and IRB approvals.
Clinical trial
Randomized Evaluation of Lumbar Injection Effectiveness and Function (RELIEF)
ClinicalTrials.gov ID
NCT07856810